News
Source Reference: Karaba AH, et al "Antibody response to respiratory syncytial virus vaccination in immunocompromised persons" JAMA 2024; DOI: 10.1001/jama.2024.25395.
Protection against RSV derived from preF IgG antibodies waned 6 months after infection in an analysis of patients with confirmed disease and household contacts.
Respiratory syncytial virus, or RSV, kills 10,000 to 13,000 older adults annually. Here’s why Dr. Leana Wen recommends people get the new RSV vaccines available for older people, pregnant people ...
Serum polymerase chain reaction obtained before treatment with intravenous immunoglobulin (IVIG) for West Nile virus (WNV) RNA (Roche Molecular Systems, Pleasanton, CA), including WNV IgM and IgG ...
Hosted on MSN4mon
AIM Vaccine submits mRNA RSV vaccine for FDA clinical trials - MSNAIM Vaccine Co., Ltd., a leading PRC vaccine company, announced today that its independently developed mRNA RSV (respiratory syncytial virus) vaccine has recently been submitted for clinical ...
Cases of respiratory syncytial virus, known as RSV, have surged, the flu season has come early, and covid-19 cases are rising. Here’s what you need to know.
Temperatures are dropping and the risk of COVID-19 and influenza are up. And for the last few months, patients with a different malady — respiratory syncytial virus, known as RSV — have been ...
A quadruple whammy of viruses – flu, COVID, norovirus, and respiratory syncytial virus, or RSV – is hitting the U.S. as the year comes to a close. The Centers for Disease Control and ...
Respiratory syncytial virus (RSV) can affect people of all ages. But RSV in babies is most serious. Learn about the symptoms and when to get help.
Respiratory virus cases rise among children 02:05. A family vacation turned into a trip to the emergency room for April Joines and her 6-year-old daughter, Lillian, who suffers from asthma and was ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results